To further explore the pathological roles of DLEU2 in prostate cancer, we first established DLEU2 overexpression and knockdown systems using pcDNA3.1-DLEU2 and sh-DLEU2 in PC-3 and DU145 cells. This evidence concerns the gene DLEU2 and prostate carcinoma.